Literature DB >> 14993779

Predictors of restenosis after implantation of 2.5 mm stents in small coronary arteries.

Iijima Raisuke1, Ikari Yuji, Miyazawa Akiyoshi, Nakajima Hiroyoshi, Hara Kazuhiro.   

Abstract

BACKGROUND: The results of stent implantation for small coronary disease have been inconclusive. The purpose of the present study was to evaluate the factors in predicting the risk of angiographic restenosis after 2.5-mm stent implantation for small coronary arteries. METHODS AND
RESULTS: The study group comprised 134 consecutive patients who had a reference small coronary artery with diameter from 1.8 mm to 2.5 mm on quantitative coronary angiography and who had been successfully treated by stent implantation with a 2.5-mm stent. Of the 134 patients, 55 had angiographic restenosis (41%). The rate of target lesion revascularization was 32%. Diabetes mellitus, acute coronary syndrome, lesion length, bifurcation lesion, lower left ventricular ejection fraction (LVEF), stent strut, stent/artery ratio, and stent length were identified as predictors of restenosis by univariate analysis. Subsequent multivariate analysis revealed that lower LVEF (odds ratio (OR) 3.37, p=0.01), bifurcation lesion (OR 2.47, p=0.04), thicker stent strut (OR 2.30, p=0.04), and longer stent length (OR 1.05, p=0.02) were significant predictors of restenosis.
CONCLUSIONS: Two pre-interventional factors (reduced left ventricular function and bifurcated lesion) and 2 procedure-related factors (thickness of stent strut and total stent length) were identified as predictors of restenosis. These factors should be taken into account when deciding on the percutaneous coronary intervention strategy for small coronary artery disease.

Entities:  

Mesh:

Year:  2004        PMID: 14993779     DOI: 10.1253/circj.68.236

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  3 in total

1.  In vitro and in vivo degradation of poly(D, L-lactide-co-glycolide)/amorphous calcium phosphate copolymer coated on metal stents.

Authors:  Xiaodong Ma; Shizu Oyamada; Tim Wu; Michael P Robich; Hao Wu; Xingwei Wang; Bryan Buchholz; Stephen McCarthy; Cesario F Bianchi; Frank W Sellke; Roger Laham
Journal:  J Biomed Mater Res A       Date:  2011-01-25       Impact factor: 4.396

2.  Paclitaxel/sirolimus combination coated drug-eluting stent: in vitro and in vivo drug release studies.

Authors:  Xiaodong Ma; Shizu Oyamada; Fan Gao; Tim Wu; Michael P Robich; Hao Wu; Xingwei Wang; Bryan Buchholz; Stephen McCarthy; Zhiyong Gu; Cesario F Bianchi; Frank W Sellke; Roger Laham
Journal:  J Pharm Biomed Anal       Date:  2010-11-10       Impact factor: 3.935

3.  Trans-iliac rat aorta stenting: a novel high throughput preclinical stent model for restenosis and thrombosis.

Authors:  Shizu Oyamada; Xiaodong Ma; Tim Wu; Michael P Robich; Hao Wu; Xingwei Wang; Bryan Buchholz; Stephen McCarthy; Cesario F Bianchi; Frank W Sellke; Roger Laham
Journal:  J Surg Res       Date:  2010-12-09       Impact factor: 2.192

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.